{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:39:42Z","timestamp":1772026782623,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    We identified 9 cases of primary high-grade serous-like carcinoma (HG-SL-Ca) of the breast that displayed the morphology of high-grade serous carcinoma of M\u00fcllerian origin. These cases could represent a new entity of breast carcinoma. This study included 9 cases of HG-SL-Ca of the breast. Extensive clinicopathologic features and outcome data were available and evaluated in 8 cases. We, for the first time, performed whole exome sequencing (WES) on 6 of these cases to identify pathogenic germline and somatic genetic mutations and conducted gene pathway enrichment analyses. Six cases were triple negative; 2 were HER2 positive, and 1 was ER+\/PR+\/HER2-. Eight of the 9 cases had high nuclear grade and the other 1 had intermediate nuclear grade. Six patients received chemotherapy; the patient with ER+\/PR+\/HER2-cancer received hormonal therapy only, and 1 patient with dementia did not receive any systemic therapy. Follow-up data showed 2 patients had distant metastasis and 1 had chest wall recurrence. Two patients died of disease, including 1 patient receiving palliative care and 1 with lung and pleural metastasis. Most of the cases were positive for GATA3 immunohistochemistry (IHC) staining and all were negative for PAX8. All except for 1 case (focally positive) were negative for WT1 nuclear stain. Aberrant p53 IHC staining patterns were observed in 6 cases. WES analyses showed 26 genes with pathogenic germline mutations and 28 genes with pathogenic somatic mutations in these cases that were in the ACR GENIE mutated gene list. Pathway analyses showed that these genes with pathogenic germline or somatic mutations were enriched in the PI3K-AKT-mTOR pathway, WNT pathways, and death receptor pathway.\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    was recurrently mutated, containing somatic variants in 4 cases, and all these 4 cases had aberrant p53 IHC staining patterns. We, for the first time, performed WES analyses on HG-SL-Ca of the breast. The majority of HG-SL-Ca were triple negative or HER2 positive with high nuclear grade. Patients with HG-SL-Ca of the breast had a poor prognosis. Our pathway analyses showed that genes containing pathogenic germline or somatic mutations were enriched in the PI3K-AKT-mTOR pathway, WNT pathways, and death receptor pathway, which could provide potential targeted treatment options.\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    was recurrently mutated in 4 cases and all these 4 cases had aberrant p53 IHC staining patterns.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002423","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:09:25Z","timestamp":1747994965000},"page":"1133-1142","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathologic and Whole Exome Sequencing Analyses of High-Grade Serous Carcinoma-Like Carcinoma of the Breast Reveal Unique Genetic Profile and Poor Clinical Outcome"],"prefix":"10.1097","volume":"49","author":[{"given":"Wen-Yu","family":"Hsiao","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thi Truc Anh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaibo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linsheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Emory University School of Medicine, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0995-1721","authenticated-orcid":false,"given":"Xiaoxian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"R2-20251022","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1066896913501381","article-title":"Breast carcinoma with tubulopapillary features: a variant of papillary carcinoma with a stronger correlation with predictors of adverse prognosis","volume":"22","author":"Darvishian","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"R3-20251022","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1177\/10668969231209780","article-title":"Breast carcinoma with tubulopapillary features has a distinct immunophenotypic and molecular signature: a report of two tumors and literature review","volume":"32","author":"Carrasco-Tenezaca","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"R4-20251022","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/1066896919892699","article-title":"Tubulopapillary carcinoma: an aggressive variant of invasive breast carcinoma with a micropapillary DCIS-like morphology","volume":"28","author":"Guerrieri","year":"2020","journal-title":"Int J Surg Pathol"},{"key":"R5-20251022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0110-13","article-title":"Exome sequencing makes medical genomics a reality","volume":"42","author":"Biesecker","year":"2010","journal-title":"Nat Genet"},{"key":"R6-20251022","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41525-022-00295-z","article-title":"Best practices for the interpretation and reporting of clinical whole genome sequencing","volume":"7","author":"Austin-Tse","year":"2022","journal-title":"NPJ Genom Med"},{"key":"R7-20251022","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"Powering precision medicine through an international consortium","volume":"7","year":"2017","journal-title":"Cancer Discov"},{"key":"R8-20251022","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/humu.24434","article-title":"Mutation update: the spectra of PLEC sequence variants and related plectinopathies","volume":"43","author":"Vahidnezhad","year":"2022","journal-title":"Hum Mutat"},{"key":"R9-20251022","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1242\/dev.02783","article-title":"Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation","volume":"134","author":"Zhang","year":"2007","journal-title":"Development"},{"key":"R10-20251022","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41419-022-05249-y","article-title":"An update regarding the role of WNK kinases in cancer","volume":"13","author":"Xiu","year":"2022","journal-title":"Cell Death Dis"},{"key":"R11-20251022","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4143\/crt.2019.497","article-title":"PIK3CA H1047R mutation associated with a lower pathological complete response rate in triple-negative breast cancer patients treated with anthracycline-taxane-based neoadjuvant chemotherapy","volume":"52","author":"Guo","year":"2020","journal-title":"Cancer Res Treat"},{"key":"R12-20251022","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/his.15385","article-title":"Serous-like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours","volume":"86","author":"Krings","year":"2025","journal-title":"Histopathology"},{"key":"R13-20251022","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","article-title":"Mutational processes shape the landscape of TP53 mutations in human cancer","volume":"50","author":"Giacomelli","year":"2018","journal-title":"Nat Genet"},{"key":"R14-20251022","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jmcb\/mjab049","article-title":"A potential synthetic lethal strategy with PARP inhibitors: perspective on \u2018Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP\u2019","volume":"13","author":"Hao","year":"2021","journal-title":"J Mol Cell Biol"},{"key":"R15-20251022","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"R16-20251022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-023-07233-2","article-title":"High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy","volume":"205","author":"Wood","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"R17-20251022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clbc.2019.09.003","article-title":"Clinicopathologic factors associated with response to neoadjuvant Anti-HER2-directed chemotherapy in HER2-positive breast cancer","volume":"20","author":"Meisel","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"R18-20251022","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/ajcp\/aqw045","article-title":"Biomarkers predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer","volume":"145","author":"Li","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"R19-20251022","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10549-020-05819-8","article-title":"Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+\u00a0and FOXP3+\u00a0immune cells in HER2-positive breast cancer treated with neoadjuvant therapies","volume":"183","author":"Zhao","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"R20-20251022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.humpath.2017.01.004","article-title":"Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers","volume":"64","author":"Krishnamurti","year":"2017","journal-title":"Hum Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:00:25Z","timestamp":1761138025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002423","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}